Skip to content

EXEL

Exelixis, Inc.

NASDAQ · USHealthcareBiotechnology
$55.53-0.70%

Price as of Jul 20, 2026

EXEL news

Exelixis, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026

    Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 – Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.exelixis.com%2F&esheet=54519867&newsitemid=20260421129215&lan=en-US&anchor=Exelixis%2C+Inc.&index=1&md5=a8198a0946bcdfadceb175182e5611b8) (Nasdaq: EXEL) announced today that its first quarter 2026 financial results will be released on Tuesday, May 5, 2026 aft

    Business Wire ·